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Abstract
Toroviruses are gastroenteritis causing agents that infect different animal species and humans. To date, very little is known
about how toroviruses cause disease. Here, we describe for the first time that the prototype member of this genus, the equine
torovirus Berne virus (BEV), induces apoptosis in infected cells at late times postinfection. Observation of BEV infected cells by
electron microscopy revealed that by 24 hours postinfection some cells exhibited morphological characteristics of apoptotic
cells. Based on this finding, we analyzed several apoptotic markers, and observed protein synthesis inhibition, rRNA and DNA
degradation, nuclear fragmentation, caspase-mediated cleavage of PARP and eIF4GI, and PKR and eIF2a phosphorylation, all
these processes taking place after peak virus production. We also determined that both cell death receptor and mitochondrial
pathways are involved in the apoptosis process induced by BEV. BEV-induced apoptosis at late times postinfection, once viral
progeny are produced, could facilitate viral dissemination in vivo and contribute to viral pathogenesis.
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Introduction
Toroviruses are enteric (and probably respiratory) viruses which
infect different animal species and humans and cause diarrhea.
They are positive-sense, single stranded RNA enveloped viruses
that, together with coronaviruses, belong to the Coronaviridae family
of the Nidovirales order [1,2]. There are four torovirus species
recognized by the ICTV, established according to the animal host
that they infect: bovine torovirus (BToV), porcine torovirus
(PToV), human torovirus (HToV) and equine torovirus (EToV)
(ICTV web site: www.ictvonline.org). The latter virus was the first
torovirus identified, isolated in 1972 from the faeces of a horse in
Berne (Switzerland), and named Berne virus or BEV [3]. For a
long time BEV was the only strain of the genus that could be
grown in cell culture, and therefore it is the most thoroughly
studied at the molecular level, and is the prototype member of the
genus. Nonetheless, the propagation of different BToV strains in
the human HRT-18 cell line has been recently described [4,5].
The torovirus genome consists of a single RNA molecule of
about 25–30 kb. The 59 two thirds contain two large and over-
lapping open reading frames, ORF1a and ORF1b, that code for
the replication machinery. The last third of the genome contains
four open reading frames, ORFs 2–5, coding for the spike (S),
membrane (M), hemagglutinin-esterase (HE) and nucleocapsid (N)
structural proteins [6]. In BEV the HE gene is partially deleted
when compared with other torovirus strains, though the cor-
responding mRNA is produced [7].
Since their identification in 1972, toroviruses have been poorly
studied, and many issues regarding torovirus infections remain
unexplored. Significantly, little is known about the morphological,
physiological and biochemical changes that occur in torovirus
infected cells. Investigating the complex virus-host interactions is
important to understand the basis of torovirus-induced disease.
There are a few studies about torovirus pathogenesis that were
performed with BToV, since it is the only torovirus that has been
successfully propagated in experimental infections. In those
studies, gnotobiotic and colostrum deprived calves, infected orally
or intranasally with BToV, developed moderate to severe diar-
rhea. Infected animals were sacrificed sequentially during the early
stages of infection, and intestinal tissue samples were obser-
ved by light and electron microscopy. Cytopathological changes
associated with BToV infection were observed in enterocytes from
the lower half of the villi, extending into the crypts throughout the
lower small intestine, large intestine and dome epithelial cells [8,9].
Enterocytes showed signs of severe vacuolar degeneration, necrosis
and exfoliation. It was suggested that the primary site of infection
is in the crypt cells, and that infected cells migrate up to the villous
before being shed as the viral cytopathic effect (CPE) develops [10].
On the other hand, the effects of infection in the host with the
closely related coronaviruses have been more thoroughly investi-
gated, especially since the emergence of the human coronavirus
causing the severe and acute respiratory syndrome (SARS-CoV).
Significantly, occurrence of cell death by apoptosis has been
observed during infection with several coronaviruses: the mouse
hepatitis virus (MHV) [11,12,13], transmissible gastroenteritis
virus (TGEV) [14,15,16], infectious bronchitis virus (IBV) [17,18],
canine coronavirus (CCoV) [19,20], feline infectious peritonitis
virus (FIPV) [21], equine coronavirus [22], and the human
coronaviruses OC43 [23], 229E [24] and SARS-CoV [25,26]. The
induction of apoptosis represents one of the major components of
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the host antiviral responses. Nonetheless, viruses establish intricate
and complex interactions with the host to regulate apoptosis to
ensure a successful replication cycle that allows the production and
spread of virus progeny to neighbouring cells [27,28]. In fact, many
viruses have been reported to inhibit apoptosis early in infection to
facilitate the viral replication and to induce apoptosis at later times
postinfection to inhibit the inflammatory response and favour viral
dissemination [28,29,30].
Two cellular proteins which are key effectors of the initial
antiviral response triggered by interferon (IFN) and which have
been related to the induction of apoptosis, are the protein kinase R
(PKR) and the RNase L. Both proteins become activated by
double-stranded RNA (dsRNA), and activation of each of these
two proteins results in protein synthesis inhibition and apoptosis
[31,32,33,34,35,36,37]. Upon activation, PKR phosphorylates
the alpha subunit of the eukaryotic initiation factor 2 (eIF2a)
impairing its activity, and then causing inhibition of host-cell
translation initiation [38,39,40]. On the other hand, RNase L,
which is activated by 2959oligoadenylates produced upon dsRNA
activation of the 2959oligoadenylate synthetase, degrades both
viral and host single-stranded RNA (ssRNA), including ribosomal
RNA [41,42]. Therefore PKR and RNase L activation effectively
inhibits viral and cellular gene expression, and the ultimate con-
sequence of their activation is the induction of apoptotic pathways
leading to the removal of the infected cell.
Caspases are intracellular proteases (cysteine-dependent aspar-
tate-specific proteases) that play an essential role during apoptosis.
There are two main apoptosis pathways regulated by caspases: the
extrinsic or cell death receptor pathway, and the intrinsic or
mitochondrial pathway. The former is initiated mainly by binding
of an extracellular ligand to a death receptor, which in turn aggre-
gates and recruits, through adapter proteins, procaspase-8 mole-
cules, leading to their activation into caspase-8. The mitochondrial
pathway is activated after an intracellular signal such as DNA
damage, leading to the release of cytochrome c from mitochon-
dria, which binds to the adaptor molecule apoptotic protease
activating factor-1 (Apaf-1), and the complex binds to procaspase-
9, promoting its autocleavage into caspase-9.
Both pathways converge at the activation of executioner caspases,
namely caspase-3, -6,-7, and -10. Caspase-3 is the primary execu-
tioner caspase that cleaves most of the cellular substrates examined
[43], leading to the characteristic morphological features of
apoptosis, such as nuclear shrinking and membrane blebbing [44].
Both cell death receptor and mitochondrial apoptosis signaling
pathways can also intersect at the caspase-8-mediated cleavage of
Bid, a proapoptotic Bcl2 family member, which promotes cyto-
chrome c release from the mitochondria, and has been shown to
be implicated in apoptosis induced by viruses [45,46,47,48].
Here, we report the first biochemical study of the effects caused
by a torovirus in the infected cells, and show that typical mor-
phological and biochemical features of apoptosis are induced in
BEV infected cells. For the elucidation of the underlying me-
chanisms, we examined several apoptotic markers, and we found
that both intrinsic and extrinsic apoptotic pathways are involved,
being the second likely activated through Bid cleavage by caspase-8.
To our knowledge, nothing was known about the torovirus-induced
alteration on cellular functions and signaling pathways, which would
have a profound impact on cell viability and virus pathogenesis.
Materials and Methods
Cells and viruses
Equine dermal (E. Derm) cells (NBL-6, ATCC CCL-57), and
human fetal lung fibroblasts (MRC-5, ATTC CCL-171), kindly
provided by R. de Groot (Utrecht University, Utrecht, The
Netherlands) and R. E. Randall (University of St. Andrews,
Scotland, UK) respectively, were cultured at 37uC, 5% CO2 and
98% humidity, in Dulbecco’s modified Eagle’s medium (DMEM;
Invitrogen, corp) supplemented with 15% and 10% fetal calf
serum (FCS) respectively, non-essential aminoacids (1%), genta-
micin (50 mg/ml), penicillin (100 U/ml), streptomycin (100 mg/
ml) and fungizone (0.5 mg/ml).
Equine torovirus BEV (strain P138/72) [3] was obtained from
R. de Groot (Utrecht University, Utrecht, The Netherlands). The
virus was grown in E. Derm cells and was partially purified by
ultracentrifugation over 20% sucrose cushion. The virus was
titrated by plaque assay as previously described [49].
Ultraviolet (UV) inactivation of BEV
A preparation of partially purified virus was placed in an open
tube under an UV lamp (PHILIPS 15W/G15 T8) inside a laminar
flow hood, and maintained exposed to UV light for 30 min. Viral
inactivation was confirmed by titration of the same viral sample
before and after UV irradiation.
Phase-contrast microscopy
E. Derm cells were mock-infected and infected with BEV [5
plaque-forming units (pfu)/cell] in 12-well plates. At 24 and
48 hours postinfection (hpi) cells were examined under an inverted
phase-contrast microscope (LEICA DMI6000B) with a 106/0.30
objective, and images were acquired with a digital camera (CCD
Hamamatsu Orca R2).
Electron microscopy
Monolayers of E. Derm cells, mock-infected or infected with
BEV (5 pfu/cell), were fixed in situ 24 hpi with a mixture of 4%
paraformaldehyde (PFA) and 2% glutaraldehyde in 0.1 M
phosphate buffer pH 7.4 for 1 h at room temperature. Fixed cells
were removed from the dishes, washed in phosphate buffer and
processed for embedding in the epoxy resin TAAB-812 (TAAB
Laboratories-England UK) by methods previously described [50].
Ultrathin sections of embedded samples were stained with
saturated uranyl acetate and lead citrate and examined at 80 kV
in a Jeol JEM-1010 (Tokyo, Japan) electron microscope. Pictures
were acquired with a Bioscan 792 digital camera (Gatan, Inc.).
Metabolic labeling
E. Derm and MRC-5 cells were seeded in 24-well plates, and
infected with BEV (5 pfu/cell). At the indicated times postinfec-
tion, cells were subjected to a 30 min pulse, at 37uC with
100 mCi/ml of [35S]Met-Cys (GE Healthcare), and DMEM
without Met and Cys. Cell extracts were lysed in Laemmli buffer
with 5% b-mercaptoethanol, and proteins were denatured by
boiling for 5 min, separated by SDS-PAGE in 12% polyacryl-
amide gels, and visualized after staining of the gel with coomassie
blue. Labeled proteins were detected by autoradiography of the
dried gels.
Apoptosis quantitation by analysis of the nuclear DNA
content by flow cytometry
The different stages of cell cycle and the percentage of cells with
subG0-G1 DNA content were analyzed by propidium iodide (PI)
staining and flow cytometry [51]. E. Derm and MRC-5 cells were
seeded in 6-well plates, and infected with BEV (5 pfu/cell). In
some experiments, after virus adsorption, cells were treated with
the caspase inhibitors z-IETD-fmk (caspase-8), z-LEHD-fmk
(caspase-9) and z-VAD-fmk (general inhibitor) (Calbiochem), each
BEV-Induced Apoptosis
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at a final concentration of 50 mM. At the indicated times, all the
cells from each well were collected; the floating cells were taken
with the medium and combined with those still adhered to the
plastic recovered by trypsinization. Cells were washed with ice-
cold phosphate-buffered saline (PBS), and permeabilized with 70%
ethanol in PBS at 4uC overnight. Later, cells were washed three
times with PBS, incubated 45 min at 37uC with RNase-A
(0.1 mg/ml) and stained with PI (10 mg/ml). The percentage of
cells with hypodiploid DNA content was determined by flow
cytometry. Data were acquired on 104 cells per sample in a
Coulter EPICS XL-MCL cytometer with Argon 488 laser.
Immunofluorescence
For nuclei staining of apoptotic cells, E. Derm and MRC-5 cells
were seeded over coverslips, infected with BEV (5 pfu/cell), and
fixed with 4% PFA at the indicated times. Cells were stained with
Hoechst 33258 (0.5 mg/ml, Sigma), and the images were obtained
in a Leica DMRD epifluorescence microscope, using the suitable
filter (360–400 nm).
rRNA analysis
To analyze rRNA degradation, E. Derm and MRC-5 cells were
seeded in 6-well plates, and infected with BEV (5 pfu/cell). At 8,
16, 24 and 48 hpi, medium was removed, cells were washed with
PBS and lysed with 350 ml of the RLT buffer from the RNeasy
Mini kit (Qiagen), and RNA purified following the manufacturer’s
instructions. Finally, RNA was eluted with 30 ml of diethyl
pyrocarbonate-treated water, and 2 ml of each RNA sample was
analyzed in 1% agarose gel and stained using ethidium bromide
(EtBr, 0.5 mg/ml), under RNase free conditions.
Subcellular fractionation
E. Derm and MRC-5 cells grown in 6-well plates were mock-
infected or infected with BEV at a multiplicity of infection of
5 pfu/cell and collected at 24 or 38 hpi. Cells treated with
staurosporine (500 nM) for 6 h were included in the assay as a
control of cytocrome c redistribution in cells undergoing apoptosis
induced through the mitochondrial pathway. At the indicated
times cells were collected in PBS and subjected to digitonin
permeabilization as previously described [52]. Briefly, pelleted
cells were resuspended in 100 ml of an isotonic sucrose buffer
(250 mM sucrose, 10 mM Hepes, 10 mM KCl, 1.5 mM MgCl2,
1 mM EDTA, and 1 mM EGTA, pH 7.1) containing 0.05%
digitonin (Sigma), and after 2 min at room temperature disrupted
cells were centrifugated at 14.000 rpm 5 min, and the soluble
cytosolic fractions were transferred to new tubes containing 25 ml
of 56Laemmli sample buffer, and the digitonin-insoluble fractions
(membrane-bound organellar fractions) were washed once with
isotonic buffer and directly disrupted in 125 ml of 16 Laemmli
sample buffer.
Western blot analysis
Mock-infected or BEV-infected E. Derm and MRC-5 cells were
lysed at the indicated times postinfection directly in Laemmli
buffer with b-mercaptoethanol, or were subjected to subcellular
fractionation as described above, and proteins were denatured by
boiling for 5 min. Protein lysates were fractionated by SDS-PAGE
and transferred to nitrocellulose membranes (Protran, Schlei-
cher&Schuell) in a semidry blotting apparatus (BioRad) for 45 min
at 200 mA. Membranes were blocked for 1 h in PBS containing
5% nonfat dry milk and then probed with different antibodies:
rabbit polyclonal anti-PARP (1:500, Cell Signaling), rabbit
polyclonal anti-eIF4GI, that recognizes the amino (N) and carboxy
(C) terminal moieties of the eIF4GI protein (1:5000, kindly
provided by Dr. Carrasco from CBMSO, Madrid, Spain),
polyclonal anti-phosphorylated (Ser51) eIF2a (eIF2aP) (1:1000,
Biosource), polyclonal anti-eIF2a (1:500; Santa Cruz Biotechnol-
ogy), rabbit polyclonal anti-phosphorylated PKR (Thr451) (1:1000,
Invitrogen), monoclonal anti-murine PKR (B-10, 1:1000; Santa
Cruz Biotechnology), mouse monoclonal anti-b-actin (Ab8226,
Abcam), rabbit polyclonal against Bid (1:500, kindly provided by
Dr. Yin from Indiana University, Indianapolis, EEUU), a mouse
monoclonal anti-cytochrome c (1:500; Santa Cruz Biotechnology),
two rabbit polyclonal sera against the BEV nucleocapsid protein
(anti-BEV-N, 1:1000) and membrane protein (anti-BEV-M, 1:1000)
respectively [53], and a mouse monoclonal anti-S antibody (1:250).
Proteins were detected using horseradish peroxidase-labeled se-
condary antibodies (Sigma) and an enhanced chemiluminescence
Western blot detection kit (ECL, GE Health Care).
Statistical analysis
Statistical analyses were performed using Student’s two tailed t
test. Means 6 standard deviation for each sample are shown.
Results
Morphological appearance of BEV infected cells
Since little is known about the host cellular responses to
torovirus infection, we decided to examine cellular responses to
infection with BEV virus, as the prototype member of the torovirus
group. Until very recently, BEV was the only torovirus strain that
could be grown in cell culture, and E. Derm and embryonic mule
skin (EMS) cells the only cell lines described as being susceptible to
infection to date. In E. Derm cells infected with BEV at a
multiplicity of infection of 5 pfu/cell, the first signs of infection
could be detected by about 24 hpi, and CPE was seen in some
cells (compare panels A and D with B and E in figure 1). However,
extensive CPE could be observed at 48 hpi (Fig. 1, panels C and
F). On the other hand, examination by electron microscopy of E.
Derm cells infected for 24 h with BEV (5 pfu/cell) showed that
some cells presented characteristic signs of apoptosis. Figure 2
shows the comparison of the appearance of an uninfected E. Derm
cell (Panel A) with a BEV infected cell showing apoptotic cha-
racteristics such as a disorganized nucleus, chromatin condensa-
tion, membrane blebbing, and cell disassembly in vesicles (Panel B)
[54]. The number of cells showing this morphology readily in-
creases with the time postinfection (not shown), in agreement with
the CPE observed by phase-contrast microscopy. These results
suggest that BEV causes apoptosis at late times of the infection
cycle.
Protein synthesis inhibition in E. Derm and MRC-5 cells
infected with BEV
The response of mammalian cells to a variety of stimuli and
stress-inducing conditions that cause apoptosis, such as viral infec-
tions, involves a rapid inhibition of protein synthesis [55,56,57].
To analyze whether protein synthesis was affected after BEV
infection, E. Derm cells were infected with BEV (5 pfu/cell) and
metabolically labeled with [35S]Met-Cys for 30 min at the
indicated times postinfection which ranged between 4 and 32 hpi
(Fig. 3A). The proteins were analyzed by SDS-PAGE and the gels
were stained with coomassie blue and later subjected to auto-
radiography. A significant general reduction in protein synthesis
was observed at 24 and 32 hpi, although a clear decrease was
already observed by 16 hpi. The image of the coomassie blue
stained gel shows that similar amounts of protein were loaded in all
lanes (Fig. 3B). Significantly, two bands corresponding to proteins
BEV-Induced Apoptosis
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of about 17- and 20-kDa of molecular mass could be first
appreciated in the autoradiogram at 6 hpi, and the intensity of
these bands highly increased by 8 and 10 hpi, but diminished
thereafter. These two bands should correspond to BEV structural
proteins N and M respectively, although their relative mobility in
SDS-PAGE are slightly higher than previously described [58,
59,60]. The identity of the 17- and 20-kDa proteins was confirmed
by analysis of the same samples by Western blot with anti-BEV-N
and anti-BEV-M antibodies (Fig. 3C). The patterns of appearance
of both proteins were similar to those observed by metabolic
labeling (Fig. 3A). Interestingly, although the metabolic labeling
studies indicated that M and N synthesis decreases at late times of
the infection cycle, these proteins were still detected by Western
blot analysis suggesting that these proteins remain stable at late time
points. In addition, in Fig. 3A a high molecular weight protein can
be observed, the intensity of which increased from 6 to 10 hpi and
diminished from 16 hpi onwards (labeled with a solid arrowhead),
that could correspond to the 200-kDa S protein precursor [61].
Moreover, two additional faint bands in the range of 75- to
100-kDa (labeled with empty arrowheads) could be observed at
16 hpi, that could correspond to the S cleaved products. By
Western blot with a monoclonal antibody that recognizes the S
protein we observed the precursor at 8 hpi, and both, the precursor
and one of the cleaved products from 10 hpi onwards (Fig. 3C).
To further investigate the effect of BEV infection, we searched
for other cell types that could be infected by BEV. Thus, several
cell lines of different origins were subjected to an infection trial
with BEV, and we found that this virus could also grow in the
human MRC-5 cells, though the viral replication cycle is slower in
this cell type (Garzo´n et al., unpublished results). Therefore we
carried out a similar experiment to that described above, and
performed a metabolic labeling with [35S]Met-Cys in MRC-5 cells
infected with BEV (5 pfu/cell). An overall protein synthesis
reduction similar to that observed in E. Derm cells was also
observed in MRC-5 cells at 24 and 32 hpi (Fig. 3D). Again, the
intensities of whole protein profiles visualized by coomassie blue
staining were similar, indicating that equivalent amounts of
proteins were loaded in all lines (Fig. 3E). Also, the 17- and 20-
kDa viral proteins were detected, although they showed a delay in
synthesis with respect to E. Derm cells, being first detected at
8 hpi. Their identity as BEV N and M proteins, respectively, was
also confirmed by Western blot (Fig. 3F). Although in the
autoradiogram we could not distinguish the high molecular bands
corresponding to the S protein precursor and cleaved products
among the cellular proteins in these cells (Fig. 3D), by Western
Blot with the anti-S monoclonal antibody we could see the S
precursor from 10 hpi, and both precursor and one of the cleaved
products from 16 hpi onwards (Fig. 3F).
These results show that, in BEV infected cells, synthesis of both
cellular and viral proteins was drastically inhibited at late times
postinfection.
eIF2a and PKR are phosphorylated in BEV infected cells
A common mechanism for down-regulating protein synthesis
during apoptosis is through the phosphorylation of the translation
Figure 1. BEV induced CPE in E. Derm cells. E. Derm cells were mock-infected (A and D) or infected with BEV (5 pfu/cell), observed by phase-
contrast microscopy and photographed at 24 (B and E) and 48 (C and F) hpi. Panels D, E and F represent enlarged areas (36) of panels A, B and C
respectively. (Scale bars, 200 mm).
doi:10.1371/journal.pone.0020972.g001
Figure 2. Electron microscopy of BEV infected E. Derm cells. E.
Derm cells were mock-infected (A) or infected with BEV (5 pfu/cell) (B),
harvested at 24 hpi, fixed and embedded in Epoxi resin. Ultrathin
sections of 60–70 nm were stained with lead citrate and uranyl acetate
and observed by electron microscopy. Characteristic signs of apoptosis,
such as chromatin condensation, membrane blebbing and cell
disassembly, observed in the cell of panel B, were evident in some
cells infected with BEV at 24 hpi. (Scale bars, 2 mm).
doi:10.1371/journal.pone.0020972.g002
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initiation factor eIF2a [62]. PKR is one of the three Ser/Thr
cellular protein kinases known to phosphorylate eIF2a in response
to viral infection [33], leading to a block in the translation ini-
tiation [31]. Activation of PKR occurs by autophosphorylation
upon its binding to dsRNA, which in the case of virus-infected cells
is generated as a result of viral replication, or simply as a by-
product originated during replication of the viral genome. We
have observed that there is accumulation of dsRNA generated as
an intermediate product during viral replication in torovirus
infected cells (A´vila et al., unpublished results). Hence, we sought
to investigate whether eIF2a becomes phosphorylated in BEV
infected cells. For that, E. Derm and MRC-5 cells were infected
with BEV (5 pfu/cell) and at the indicated times postinfection cells
were collected and subjected to Western blot analysis. As shown in
figure 4A, a transient eIF2a phosphorylation was observed in both
cell lines starting at 8 hpi and decreasing by 24 and 32 hpi.
Therefore, next we wanted to determine if PKR could be
responsible for eIF2a phosphorylation after BEV infection.
Significantly, in both cell lines PKR phosphorylation was first
observed at 6 hpi and increased at 8 hpi (Fig. 4A). In E. Derm
Figure 3. Inhibition of protein synthesis in BEV infected E. Derm and MRC-5 cells. E. Derm and MRC-5 cells were mock-infected (M) or
infected with BEV (5 pfu/cell), and metabolically labeled with [35S]Met-Cys for 30 min at the time postinfection indicated on the top of the figures.
Cellular extracts were analyzed by SDS-PAGE (12% polyacrylamide), and proteins were visualized after staining of the gels with coomassie blue (B and
E), and labeled proteins were detected by autoradiography of the dried gel (A and D). The two major proteins that arise throughout the infection with
BEV, identified as the structural M and N proteins, are indicated with arrows at the right side of each figure. A high molecular weight protein band
(denoted by a solid arrowhead) and two other faint bands (denoted by empty arrowheads) likely representing the S precursor and cleaved products
respectively, were also observed in [35S]Met-Cys-labeled extracts from E. Derm cells. The positions of the molecular mass markers in kDa are
represented on the left. (C and F) Western blot analysis of E. Derm and MRC-5 cells infected with BEV (5 pfu/cell), collected at the indicated hpi and
reacted with specific antibodies against the BEV structural S, M and N proteins (indicated at the right of the corresponding panel). The S precursor
(denoted by a solid arrowhead), the 100 kDa cleaved product (denoted by an empty arrowhead), and the position of a protein recognized
unespecifically by the anti-S monoclonal antibodies (denoted by an arrow) are indicated in the upper panels.
doi:10.1371/journal.pone.0020972.g003
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cells similar phosphorylation dynamics were observed for both
eIF2a and PKR. Western blot analysis of these samples with
antibodies against total eIF2a and PKR were also performed for
sample loading control, however all the antibodies tested against
PKR failed to recognize the protein from E. Derm cells.
These results indicate that the protein synthesis blockade ob-
served after BEV infection seems to be related to the phosphor-
ylation of eIF2a, which could be caused by PKR.
RNA degradation in BEV infected cells
dsRNA is also known to activate the cellular 2959-A-dependent
RNase L. RNA degradation by RNase L is therefore another
cellular mechanism implicated in protein synthesis inhibition at a
translational level, and an apoptosis inducer [34,35,36,37]. Hence,
we wanted to determine whether rRNA degradation occurs in
BEV infected cells, and for this we analyzed 18S and 28S rRNA
pattern. rRNA was analyzed in E. Derm and MRC-5 cells infected
with BEV (5 pfu/cell) at the indicated times between 8 and 48 hpi.
As shown in figure 4B, a similar rRNA degradation pattern was
observed in both cell lines, with the 28S RNA being degraded at
earlier time points than the 18S; degradation of 18S RNA is only
clearly apparent in both cells lines at 48 hpi.. Therefore, these
results reinforce the hypothesis that BEV causes apoptosis in
infected cells, and suggests that the protein synthesis inhibition is
also related to RNA degradation.
Caspase cascade activation after BEV infection
Caspases, the central executioners of apoptosis, are involved in
most of the morphological changes observed in an apoptotic cell.
Two well-known substrates of the executioner caspases are the
Poly (ADP-ribosylating) Protein 1 (PARP1), a 116-kDa enzyme
implicated in the DNA-damage repair, and the eIF4GI initiation
factor, the scaffolding protein of the translation initiation complex.
Caspase-mediated cleavage of PARP1 produces a 89-kDa C
terminal fragment and a 24-kDa N terminal fragment, and renders
the protein inactive [63]. The eIF4GI is a 220-kDa protein that
can be cleaved in two different places during apoptosis, giving rise
to a 76-kDa central fragment and two other fragments of about
50-kDa, corresponding to the N and C termini [64,65]. To
determine whether the caspase-cascade system was activated upon
BEV infection, the potential degradation of both factors was
studied. E. Derm and MRC-5 cells were infected with BEV
(5 pfu/cell), and cell extracts were collected at 8, 16, 24, 38 and
48 hpi. Mock-infected cells were used as a control. Samples were
analyzed by SDS-PAGE (10% polyacrylamide gel) and subjected
to Western blot analysis with a commercial anti-PARP antibody
that recognizes both the 116-kDa intact protein and the 89-kDa
fragment, and with a polyclonal antibody that recognizes both the
N and C termini of eIF4GI. Appearance of the PARP 89-kDa
fragment and a concomitant decrease of the 116-kDa band started
between 8 and 16 hpi in E. Derm cells, and at 38 hpi in MRC-5
cells (Fig. 5A, upper panel). eIF4GI presented a similar pattern,
with the appearance of the 50-kDa band and the concomitant
decrease of the 220-kDa band at 24 hpi onwards in E. Derm cells,
and at 38 hpi in MRC-5 cells (Fig. 5A, bottom panel). From these
results we concluded that BEV-induced apoptosis involves caspase
activation.
We also sought to determine whether virus replication was a
prerequisite for virus-induced apoptosis. For this, E. Derm and
MRC-5 cells were inoculated with BEV (2.5 pfu/cell) or with an
Figure 4. Analysis of factors likely responsible for protein synthesis inhibition. (A) For the analysis of eIF2a and PKR phosphorylation, E.
Derm and MRC-5 cells were infected with BEV (5 pfu/cell), collected at different hpi, as indicated on the top of the figure, and subjected to Western
blot analysis with antibodies against phosphorylated (a-eIF2a-P) and total (a-eIF2a-T) eIF2a, and phosphorylated (a-PKR-P) and total (a-PKR-T) PKR.
The positions of molecular mass markers in kDa are indicated at the left of each panel. (B) For the rRNA degradation analysis, E. Derm and MRC-5 cells
were infected with BEV (5 pfu/cell) and collected at the hpi indicated on the top of the figure. RNA from the infected and mock-infected (M) cell
cultures was purified and the amount of RNA corresponding to 26105 cells was fractionated in each lane of a 1% agarose gels stained with EtBr. The
positions of the 28S and 18S rRNA molecules are indicated at the left of the figure.
doi:10.1371/journal.pone.0020972.g004
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equivalent amount of UV-inactivated BEV. At 24 hpi cells were
harvested and analyzed by Western blot with the anti-eIF4GI and
anti-PARP antibodies. We did not observe any CPE on the cells
treated with UV-inactivated virus (data not shown), and neither of
the two caspase substrates was processed in these cells (Fig. 5B),
suggesting that BEV apoptosis triggering is dependent upon viral
replication.
DNA degradation in BEV infected cells
One of the main characteristics of an apoptotic cell is the
nuclear morphological alteration, due to DNA fragmentation,
chromatin condensation, and apoptotic body formation [54]. We
had previously observed by electron microscopy that, by 24 hpi,
the nuclei of about 10% of BEV-infected cells were disorganized,
and we wanted to examine the nuclear morphology at later times
postinfection. Therefore, E. Derm cells were infected with BEV
(5 pfu/cell), or mock-infected, and a kinetic study was performed,
fixing cells with PFA at different times between 10 and 48 hpi.
Nuclei were stained with Hoechst and observed by fluorescence
microscopy (Fig. 6A). While nuclei from control cells were all
evenly stained, abnormal brighter and smaller nuclei were instead
observed in some BEV infected cells at late times postinfection. At
30 hpi we found a small percentage of apoptotic nuclei (6%),
which increases to 18% at 38 hpi. At 48 hpi the percentage of
apoptotic nuclei recorded was 12%, but there has to be borne in
mind that at this time postinfection many cells were already
detached and floating in the culture medium, and therefore, the
percentage of apoptotic cells at this time point was underestimated
by this approach.
Therefore, in order to quantify more efficiently the kinetics of
appearance of apoptotic nuclei, we analyzed the nuclear DNA
content by flow cytometry after PI staining. Apopotic nuclei show
a reduced fluorescence when compared to non-apoptotic nuclei,
and appear as a broad subG0-G1 peak [51]. Hence, E. Derm and
MRC-5 cells infected with BEV (5 pfu/cell) were harvested
(monolayers and medium) at 10, 24, 38 and 48 hpi, stained with
PI and analyzed by flow cytometry. Fig. 6B shows a representative
example of the cell cycle profiles obtained from E. Derm and
MRC-5 cells where we could observe a gradual increase in the
amount of cells present in the subG0-G1 peak with increasing time
postinfection, although broader peaks were observed in E. Derm
cells than in MRC-5 cells. The assay was performed three times,
and the results of the three experiments are represented in Fig. 6C.
As shown in the figure, 11.1763.05% of E. Derm cells infected
with BEV appear in the subG0-G1 peak at 24 hpi, and this
percentage progressively increased at 38 and 48 hpi (28.1366.31
and 43.4767.64% of apoptosis respectively). As observed in
previous analysis of protein synthesis and cleavage of caspase
substrates, in MRC-5 cells the apoptotic process is delayed, with
5.3760.97% of apoptotic cells at 38 hpi, increasing to 9.660.46 at
48 hpi.
Both extrinsic and intrinsic pathways are involved in the
apoptosis induced by BEV in the infected cells
Once we have determined that BEV infection causes apoptosis
in both E. Derm and MRC-5 cells, and knowing that the caspase
cascade is involved, we wanted to know which upstream caspase(s),
and therefore which apoptotic pathway(s) (death receptor and/or
mitochondrial pathway) could be involved. For that, E. Derm and
MRC-5 cells were infected with BEV (5 pfu/cell), and treated with
a general caspase inhibitor (z-VAD-fmk), a caspase-8 inhibitor (z-
IETD-fmk), or a caspase-9 inhibitor (z-LEHD-fmk), and the
percentage of cells at the subG0-G1 zone was determined at 48 hpi
by flow cytometry after PI staining. The assay was performed
twice. It was observed that, in both E. Derm and MRC-5 cells, the
general caspase inhibitor clearly protected cells against BEV-
induced apoptosis (17.6569.69 and 664.53% of apoptosis
respectively in z-VAD-fmk treated cells vs 52.4565.87 and
16.462.40 in non-treated cells), while the other two inhibitors
produced a partial reduction in the apoptosis levels, being this
decrease higher with the caspase-8 inhibitor (35.4067.35 and
8.7064.24% of apoptosis respectively) than with the caspase-9
inhibitor (45.5067.21 and 1263.96% of apoptosis respectively)
(Fig. 7 A and B). For both E. Derm and MRC-5 cells the
difference in the level of apoptosis between non-treated cells and
cells treated with the inhibitor of caspase-9 was not statistically
significant. Nonetheless, by Western blot analysis we observed a
clear effect of this inhibitor on the cleavage of the caspase substrate
eIF4GI. For that, untreated and inhibitor-treated E. Derm and
MRC-5 cells infected with BEV were collected at 24 and 38 hpi
respectively. The cell extracts were incubated with the antibody
against eIF4GI, and with anti-BEV-N and anti-actin antibodies as
infection and load control respectively (Fig. 7C). In untreated,
BEV-infected cells, an intense 50-kDa band corresponding to
eIF4GI cleaved product was observed (lanes 1), but the protein
was almost totally protected from cleavage by the general caspase
Figure 5. Cleavage of PARP and eIF4GI in BEV infected cells. (A) E. Derm and MRC-5 cells were infected with BEV (5 pfu/cell) and collected at
different hpi, as indicated on the top of the figure. As a negative control we used mock-infected cells (M). (B) E. Derm and MRC-5 cells were inoculated
with BEV (5 pfu/cell) or UV-inactivated BEV (equivalent amount to 5 pfu/cell) and harvested at 24 (E. Derm) and 38 (MRC5) hpi. (A and B) Cell extracts
were fractionated by SDS-PAGE (10% polyacrylamide) and analyzed by Western blot with anti-PARP and anti-eIF4GI antibodies. PARP and eIF4GI full-
length proteins are indicated by solid arrowheads and their degradation products are indicated by empty arrowheads. The positions of molecular
mass markers in kDa are indicated at the left of each panel.
doi:10.1371/journal.pone.0020972.g005
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inhibitor (lanes 2), and partially protected with caspase-8 (lanes 3)
and -9 (lanes 4) inhibitors. Interestingly, cleavage of PARP was not
significantly prevented by any of the caspase inhibitors, and it was
only slightly inhibited when used at a higher concentration
(100 mM) (data not shown).
These results, also in agreement with those obtained by
observation of infected cells using light field microscopy (not
shown), reveal a trend whereby cell damage induced by apoptosis
is higher in the untreated cells, followed in first place by cells
treated with caspase-9 inhibitor, secondly by cells treated with
Figure 6. DNA degradation in BEV infected cells. (A) E. Derm cells were infected with BEV (5 pfu/cell) and a nuclei staining kinetic study was
performed. As a control, mock-infected cells were used (Mock). Cells were fixed with PFA at the indicated hpi, and nuclei were stained with Hoechst.
(B and C) Quantification of DNA degradation in BEV infected cells by cell cycle analysis with flow cytometry. E. Derm and MRC-5 cells infected with
BEV (5 pfu/cell) were fixed and PI stained at the indicated hpi. The percentages of apoptotic cells were determined as the subG0-G1 fraction. (B)
Cellular cycle graphs obtained in a representative experiment. (C) Graphic representation of the percentages of apoptotic BEV infected cells at
different hpi. Data represent the media 6 the standard deviation of three experiments.
doi:10.1371/journal.pone.0020972.g006
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Figure 7. Analysis of the effect of caspase inhibitors z-VAD-fmk, z-IETD-fmk and z-LEHD-fmk on BEV infected cells. E. Derm and MRC-
5 cells were infected with BEV (5 pfu/cell) and treated with the general caspase inhibitor (z-VAD-fmk), caspase-8 inhibitor (z-IETD-fmk) or caspase-9
inhibitor (z-LEHD-fmk) (50 mM each). Infected but untreated cells were used as a control (A, B and C). Cells were collected at 48 hpi, and the cellular
DNA content was analyzed by flow cytometry after PI staining. (A) Cell cycle graph obtained in a representative experiment. (B) Graphic
representation of the percentage of apoptotic cells 6 the standard deviation from two experiments. Asterisks indicate statistically significant
differences between the means relative to the corresponding control (**p,0.05, *p,0.1; Student’s t test). (C) E. Derm cells collected at 24 hpi, and
MRC-5 cells collected at 38 hpi were analyzed by Western blot with anti-eIF4GI antibody, and anti-BEV-N and anti-actin antibodies as infection and
load control respectively. The position of the cleaved eIF4GI protein is indicated at the left of the panel. (D) E. Derm and MRC-5 cells were infected
with BEV at 5 pfu/cell in the absence or presence of z-VAD-fmk, and the supernatants were collected at 8, 16, 24, 32 and 48 hpi and subjected to virus
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caspase-8 inhibitor, and then by cells treated with the general
caspase inhibitor. As a whole, these results indicate that although
both cell death receptor and mitochondrial pathways are im-
plicated in the BEV induction of apoptosis, the mitochondrial
pathway could be secondarily activated by caspase-8-mediated
cleavage of Bid.
Cytochrome c release from the mitochondria and
cleavage of Bid
To further ascertain the involvement of the mitochondrial
pathway in BEV-induced apoptosis we analyzed the cellular
distribution of cytochrome c at different times postinfection. For
this assay E. Derm and MRC-5 mock-infected cells or cells
infected with BEV (2.5 pfu/cell) for 24 h were fractionated into
cytosolic and membrane-bound organellar fractions as previously
described [52], and analyzed by Western blot. Cells treated with
staurosporine were used as positive control of mitochondrial
pathway activation. As shown in figure 8 in mock-infected E.
Derm cells, cytochrome c was exclusively found in the insoluble
membranous fraction (lanes 2), while in BEV-infected cells
cytochrome c release to the cytosol could be observed at 24 hpi
(lanes 3), and at a similar rate as in staurosporine-treated cells
(lanes 1). In MRC-5 cells cytochrome c was clearly present in the
mitochondria containing fraction of the differently treated cells,
but it could be only barely observed in the cytosolic fractions of
cells infected for 24 hpi, while it was clearly observed in the
cytosolic fraction of staurosporine-treated cells. This result is in
agreement with all the above results that indicate that in MRC-5
cells the apoptotic process occurs at a lower rate (see Fig. 3, 5A,
6B and 6C).
The slight reduction in the percentage of apoptotic cells upon
treatment of infected cells with the caspase-9 inhibitor could sug-
gest that the mitochondrial apoptotic pathway may be triggered by
caspase-8-mediated cleavage of the pro-apoptotic protein Bid. To
study the potential involvement of Bid in this activation we
examined Bid proteolytic processing in BEV infected cells. For
this, the cellular fractions previously obtained were also analyzed
with an anti-Bid antibody. As shown in figure 8, cleavage of Bid
into the 15-kDa pro-apoptotic active form (tBid) could be observed
in both cell lines infected with BEV (lanes 3). On the other hand,
in mock-infected cells (lanes 2) and in cells treated with
staurosporine (lanes 1) only the intact 22-kDa form of Bid was
detected. These results confirm that the mitochondrial pathway is
involved in BEV-induced apoptosis, and points to cleavage of Bid
by caspase-8 as the triggering factor.
Inhibition of BEV-induced apoptosis by the general
caspase inhibitor z-VAD-fmk does not affect viral yields
To analyze the potential effect of apoptosis on BEV replication,
E. Derm and MRC-5 cells were infected with BEV (5 pfu/cell) in
the absence and presence of z-VAD-fmk (50 mM), and superna-
tants were collected at 8, 16, 24, 32 and 48 hpi. Viral titers were
determined by plaque assay. The experiment was performed in
triplicate. As shown in figure 7D, there were not significant dif-
ferences between virus yields obtained at any of the time points
analyzed in the absence or presence of the general caspase inhi-
bitor in either cell line. Similar results were obtained when the
experiment was performed infecting both cell lines with BEV at a
low multiplicity of infection (0.05 pfu/cell) (data not shown).
Therefore, this result indicates that caspase-mediated apoptosis is
not required for virus replication and/or the release of progeny
virions.
Discussion
Toroviruses have been scarcely studied to date, and hence little
is known about both the torovirus effect on the infected cells, and
the virus-host interactions established during infection. From
studies on pathogenesis caused by BToV in experimentally
infected calves, it was described that the virus causes a CPE in
the epithelial cells of the intestine, that results in severe vacuolar
degeneration, necrosis and exfoliation of the enterocytes, inducing
villous atrophy, crypt hyperplasia and in some cases fused villi
[66]. On the other hand, initial characterization studies about
BEV infection in E. Derm or EMS cells infected in vitro showed
that cytopathological changes are apparent at about 21 hpi only in
about 10% of the cells [67]. We obtained a similar result in E.
Derm cells infected at a multiplicity of infection of 5 pfu/cell,
where at 24 hpi only some cells show characteristic cythopatic
titration. Graphic representation of the media 6 the standard deviation of three independent experiments. There were no statistically significant
differences between the values in the absence and presence of z-VAD-fmk for any of the two cell lines and at any of the time points tested (p.0.5;
Student’s t test).
doi:10.1371/journal.pone.0020972.g007
Figure 8. Cytochrome c release from the mitochondria and Bid cleavage upon BEV infection. E. Derm and MRC-5 cells were mock-
infected or infected with BEV (5 pfu/cell), harvested at 24 hpi, and fractionated into cytosolic and membrane-bound organellar (mitochondrial)
fractions. Cells treated with staurosporine for 6 h, included as a positive control for mitochondrial pathway activation, were also fractionated.
Cytosolic and mitochondrial fractions from mock-infected cells (lanes 2), cells treated with staurosporine (lanes 1) or cells infected for 24 h (lanes 3)
were analyzed by Western blot with antibodies against cytochrome c and Bid proteins. The positions of the Bid protein and the truncated Bid (tBid)
are indicated at the left of the panel B. Reactivity with anti-actin antibody was used as a load control.
doi:10.1371/journal.pone.0020972.g008
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features as cell rounding and detachment. However, extensive
CPE was observed at 48 hpi, with many cells floating in the
medium. To obtain a more detailed image of the CPE caused by
BEV, infected cells were examined by electron microscopy. We
observed that, at 24 hpi, some BEV infected cells exhibit mor-
phological changes characteristic of apoptotic cells, such as a
condensed nucleus, membrane blebbing, altered mitochondria,
and cell disassembly in vesicles. This suggests that BEV infection
could induce apoptosis, and this fact could be related to the CPE
described in BToV infected animals. The list of viruses that cause
apoptosis in infected cells has expanded significantly in the last
two decades, and it includes several coronaviruses [14,18,19,
21,22,24,68,69].
To investigate whether BEV actually causes apoptosis we sought
to obtain some biochemical evidences. E. Derm cells might not be
optimal for investigating host-interactions because it is likely that
many of the cellular proteins would not be recognized by available
antibodies. Therefore, we used also MRC-5 cells, that we have
identified as susceptible for BEV infection. By performing a
metabolic labeling in infected E. Derm and MRC-5 cells, we ob-
served that there was protein synthesis inhibition, of both cellular
and viral proteins, between 16 and 24 hpi in E. Derm cells, and
between 24 and 30 hpi in MRC-5 cells. There are several factors
likely to be involved in the induction of this protein synthesis
inhibition, common during the apoptotic onset. The generation of
dsRNA during genome replication is a usual factor among most
RNA viruses, including coronaviruses [70], and in fact, we have
observed dsRNA accumulation both in E. Derm and MRC-5 cells
infected with BEV (A´vila et al., unpublished data). dsRNA is, in
turn, an activator of the innate immune response against viral
infections [71]. dsRNA binds and activates two apoptosis triggers
that lead to protein synthesis inhibition. On one hand, it activates
29-59-oligoadenylate synthetase, leading to activation of latent
RNase L and degradation of ssRNAs [34]. Cleavage of rRNA was
observed in both cell lines from 16 hpi, suggesting that RNase L
could be activated. Cleavage of 28S rRNA was described to occur
in MHV infected cells, although in that report the authors showed
that the 28S cleavage was an early event in MHV infection that
was probably independent of apoptosis, and they argued that
another RNase of cellular or viral origin other than RNase L was
responsible for this cleavage [72]. In addition, it has been proposed
that another as yet unidentified RNase is involved in 28S RNA
specific cleavage during apoptosis [73,74,75,76]. Therefore, speci-
fic assays will be required to determine whether rRNA cleavage
observed in BEV infected cells is mediated by RNase L and/or
other ribonuclease. On the other hand, dsRNA also activates
endogenous PKR, which leads to eIF2a phosphorylation [38,
39,40]. Here we show that both PKR and eIF2a become phos-
phorylated upon BEV infection. However, we cannot discard the
possibility that any of the two other virus-activated cellular kinases
known to phosphorylate eIF2a, the PKR-like endoplasmic reticu-
lum kinase (PERK) [77] and the general control nonderepressible-
2 kinase (GCN2) [78], might be responsible for BEV-induced
eIF2a phosphorylation. In this regard, it has been described that,
in 293/ACE2 cells, SARS-CoV induces apoptosis via PKR and
eIF2a phosphorylation. However, these two events seemed not to
be connected, since inhibition of PKR expression prevented
apoptosis but not eIF2a phosphorylation. In that case PERK was
found to be the responsible kinase [70]. Therefore, the RNA
degradation plus eIF2a phosphorylation found in BEV infected
cells could contribute to the protein synthesis inhibition upon BEV
infection.
The unmistakable sign of the apoptosis induction is the
activation of a caspase cascade, which results in the proteolytic
cleavage of a series of proteins known to exert important cellular
functions [45,79]. Here we show that cleavage of PARP and
eIF4GI substrates readily occur in BEV-infected cells, both E.
Derm and MRC-5, in a time-dependent manner. These results
also suggest that eIF4GI degradation could be another factor con-
tributing to the observed protein synthesis inhibition. In addition,
the nuclei morphological changes characteristic of apoptotic cell
death and the loss of nuclear DNA content with time postinfection
determined by PI staining and analysis by flow cytometry, are all
consistent with the notion that BEV causes caspase-mediated
apoptosis.
The study of the apoptotic factors and the nuclear DNA content
at several times postinfection indicates that in E. Derm cells the
chronology of the processes could be as follows: first PKR and
eIF2a phosphorylation (starting at 6 hpi), rRNA degradation,
PARP and eIF4GI cleavage by caspases and protein synthesis
inhibition (between 16 and 24 hpi), and finally, nuclei degradation
(between 24 and 38 hpi). The analysis of most of these parameters
in BEV infected MRC-5 cells indicates that in them the apoptotic
process occurs at later times postinfection. This observation is in
agreement with the lower infection rate in these cells when
compared to E. Derm cells, as determined by the lower viral yields
(see Fig. 7D, untreated cells) and lower viral protein expression
(Fig. 3). Moreover, this result also indicates that caspase-mediated
apoptosis requires active BEV replication. In this regard, we could
not observe either the characteristic morphological features of
apoptosis or the cleavage of PARP and eIF4GI in E. Derm or
MRC-5 cells inoculated with UV-inactivated virus. Similar results
have been described with SARS-CoV [68], while in the case of
MHV it has been reported that viral replication was not required,
and it was suggested that virus fusion triggered after virus binding
to the cell receptor was sufficient to initiate the apoptosis signal
through Fas activation [12].
The analysis of both, DNA content and eIF4GI cleavage, as
well as the de visu examination of cells infected in the presence of
caspase inhibitors, showed that both the intrinsic and extrinsic
apoptotic pathways are involved. Moreover, the observed cyto-
chrome c release to the cytoplasm shows that the mitochondrial
pathway is involved. Nonetheless, the cell death receptor pathway
seems to be predominant in both cell lines since, as determined by
the analysis of the nuclear DNA content by flow cytometry,
caspase-8 inhibitor (extrinsic pathway) causes about 32% and
47% reduction in apoptosis in E. Derm and MRC-5 cells re-
spectively, compared to reductions of 13% and 27% respectively
observed after treatment with caspase-9 inhibitor (mitochondrial
pathway). Our results suggest that the mitochondrial pathway can
be activated indirectly through cleavage of the pro-apoptotic Bcl2
family member Bid by caspase-8, as it has been shown to occur in
CCoV [20] and MHV infected cells [80]. A question arises as to
how the extrinsic pathway is activated by BEV infection. In this
regard, Fas-mediated signaling has been implicated in apoptosis
in response to infection by different viruses (reviewed in [81]). The
activation of the Fas pathway may occur extracellularly through
the binding of Fas by Fas ligand (FasL) or intracellularly through
other signaling pathways. Several studies have indicated that
PKR is involved in activating Fas-dependent apoptosis indepen-
dent of FasL in response to various stress-inducing stimuli,
including virus infection [31,82,83,84,85,86]. In influenza virus
infections, early activation of PKR seems to be important for
upregulating Fas gene expression and induction of apoptosis
[86,87]. In this regard, we have observed an early induction of Fas
gene expression at the level of transcription upon BEV infection
(unpublished results). Thus, the possibility that, as in the case of
influenza virus and other viruses, Fas signaling pathway might be
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responsible for apoptosis induction in BEV infected cells merits
further investigation.
Interestingly, PARP cleavage does not seem to be inhibited
significantly by any of the caspase inhibitors used. Cleavage of
PARP is considered a biochemical hallmark of apoptosis, however
it can be regarded as an ‘‘special’’ caspase substrate, since it can be
cleaved by both caspases-3 and -7 [79]. Therefore, as opposed to
most substrates known to be cleaved during apoptosis by caspase-
3, such as gelsolin, a-fodrin, lamin, and probably eIF4GI, PARP
can be cleaved in the absence of caspase-3 [43,88] or in the
presence of caspase-3 specific inhibitor [44]. Moreover, it has been
suggested that caspase-7 is more efficient than caspase-3 for PARP
cleavage [89]. Therefore, it is possible that due to this redundancy,
PARP cleavage can still proceed in the presence of caspase inhi-
bitors. Although it has been reported that cleavage of PARP is
inhibited in Jurkat cells treated with z-VAD-fmk (100 mM) [90],
indicating that this inhibitor also blocks caspase-7, cell-type spe-
cific differences, such as the abundance of caspases, could explain
this discrepancy. Specific experiments would be required to
ascertain which caspase is cleaving PARP in cells infected with
BEV in the presence of the general caspase inhibitor z-VAD-fmk.
Our results indicate that apoptosis does not affect virus repli-
cation and/or release in vitro. We have observed that inhibition of
the apoptotic process by treating BEV infected cells, either with
low or high multiplicity of infection, with a general caspase inhi-
bitor, does not influence the amount of virus released to the medium.
Significantly, in BEV infected cells, maximum viral progeny is
already obtained by 24 hpi [67]. Therefore, the virus seems to com-
plete its replication cycle before the onset of apoptosis, a common
strategy used by several RNA viruses, and specifically by some coro-
naviruses, to overcome the effect of premature cell death [14,18,20].
In summary, our study shows that BEV infection leads to
caspase-dependent apoptotic cell death in E. Derm and MRC-5
cells. The apoptotic process induced by BEV is triggered at late
times postinfection, once the viral progeny is produced. However,
in torovirus infected animals, apoptosis could favour the viral
infection, likely facilitating the viral dissemination and pathogen-
esis, as suggested with a great number of viruses, mainly RNA
viruses that induce apoptosis in the final stages of the replication
cycle [27,28,91].
The apoptotic death of infected cells causes tissue destruction.
In the case of torovirus, the associated gastroenteritis could be
related to the apoptosis of the mucosa epithelial cells. In this
regard, it has been previously hypothesized for some coronaviruses
that apoptosis could be the pathological basis for the lesions of the
diseased tissue alteration [19,92]. Further work will be required to
delineate the pathway(s) involved in cell death and to identify the
viral and cellular factors involved in modulating torovirus-induced
apoptosis. This work can serve as a starting point in the under-
standing of the virus-host interaction during torovirus infection, a
field of research that remains almost unexplored as yet.
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